Model | Cardiovascular death | MACE | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Lp-PLA2 (as a dichotomous variable) | ||||
Unadjusted | 2.12(1.32–3.42) | 0.002 | 1.81(1.17–2.80) | 0.007 |
Model 1 | 2.19(1.35–3.54) | 0.001 | 2.00(1.29–3.10) | 0.002 |
Model 2 | 2.36(1.46–3.84) | 0.001 | 2.14(1.37–3.34) | 0.001 |
Model 3 | 2.38(1.46–3.90) | 0.001 | 2.11(1.34–3.30) | 0.001 |
Model 4 | 3.03(1.74–5.28) | < 0.001 | 2.34(1.42–3.87) | 0.001 |
Model 5 | 3.11(1.79–5.41) | < 0.001 | 2.37(1.44–3.92) | 0.001 |
Model 6 | 3.16(1.82–5.52) | < 0.001 | 2.44(1.47–4.05) | 0.001 |
Model 7a | 2.57(1.58–4.18) | < 0.001 | 2.17(1.39–3.40) | 0.001 |
Model 7b | 2.48(1.53–4.03) | < 0.001 | 2.12(1.36–3.31) | 0.001 |
Lp-PLA2(per 100U/L) (as a continuous variable) | ||||
Unadjusted | 1.18(1.05–1.32) | 0.004 | 1.01(1.00–1.02) | 0.018 |
Model 1 | 1.19(1.06–1.34) | 0.003 | 1.17(1.04–1.31) | 0.008 |
Model 2 | 1.22(1.08–1.38) | 0.001 | 1.19(1.06–1.34) | 0.004 |
Model 3 | 1.23(1.08–1.39) | 0.002 | 1.19(1.05–1.38) | 0.005 |
Model 4 | 1.42(1.18–1.70) | < 0.001 | 1.26(1.07–1.48) | 0.002 |
Model 5 | 1.45(1.20–1.74) | < 0.001 | 1.28(1.08–1.50) | 0.003 |
Model 6 | 1.47(1.21–1.78) | < 0.001 | 1.29(1.09–1.53) | 0.003 |
Model 7a | 1.25(1.10–1.41) | 0.001 | 1.20(1.07–1.36) | 0.002 |
Model 7b | 1.24(1.10–1.40) | 0.001 | 1.20(1.07–1.35) | 0.002 |